drugset / Trial / NCT02023892

Single Dose of Atorvastatin and Circulating Endothelial Microparticles

NCT02023892 ↗

Phase 4 Unknown 30 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Healthy subjects take single dose of 80mg atorvastatin, then measured their circulating endothelial microparticles and flow-mediated vasodilation in the brachial artery by ultrasound at different time points.

Timeline

Start
2014-06
Primary completion
2014-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg Oral

Indications

No indication recorded.